Tailoring symptom relief for a patient with dry eye disease demands consideration of many factors, including the causes, manifestations, and severity of symptoms, as well as a patient’s lifestyle and individual preferences. Patients rely on their Eye Care Professional’s recommendations and require professional guidance to properly manage their dry eye symptoms with the right eyedrops that target their specific needs.
Dengue is regarded as the most eminent mosquito-borne viral disease by the World Health Organisation. In Malaysia, dengue fever has the highest incidence rate among communicable diseases, with 397.71 cases per 100,000 populations. Dengue Prevention Advocacy Malaysia (DPAM), an independent advocacy group was set up to enhance dengue prevention, management, and control within the country.
Dr Jeremy Quah, Cardiology Fellow at National Heart Institute, talks about a rare disease known as transthyretin amyloidosis (ATTR).
Amyloidosis is the extracellular tissue deposition of fibrils. There are two major forms of cardiac amyloidosis, namely light-chain amyloidosis (AL) and ATTR-CM. The clinical manifestations of ATTR-CM can vary greatly but essentially it presents as either new or worsening heart failure or new conduction system disease.
Atrial fibrillation (AF) is one of the most prevalent forms of cardiac arrhythmias, particularly among the ageing population. It is projected to affect about 8 and 17 million individuals in the United States and Europe in 2050, respectively. Although the prevalence of AF among Asians is relatively lower, the disease burden is high owing to the growing ageing population; approximately 72 million individuals are expected to receive an AF diagnosis in the next few decades. Stroke is a clinically important complication observed in patients with AF as its incidence rate is 4- to 5-fold higher than that in patients without AF. In particular, Asians have a higher incidence of AF-related risks of bleeding and stroke when compared with non-Asians. The annual risk of ischaemic stroke in Asian patients with AF was reported to be approximately 3%. As such, stroke prevention is an important aspect in the management of AF.
Paediatric patients with spinal muscular atrophy (SMA) have increased chances of survival and improved quality of life when managed by a multidisciplinary team of healthcare professionals. Dr Poorani Anandakrishnan, a paediatric neurologist from Hospital Tunku Azizah, explains how a multidisciplinary team can contribute to the optimal management of SMA patients.
At the recent 20th Malaysian Society of Haematology Annual Scientific Meeting, Associate Professor Dr Azlan Husin, clinical haematologist, Hospital USM, discussed the diagnosis and treatment of polycythaemia vera (PV). Subsequently, he explored the issue of hydroxyurea intolerance and resistance in PV.
Dr Shalini C Sree Dharan, a consultant endocrinologist, discusses the benefits of treatment options for type 2 diabetes mellitus (T2DM) that also address a patient’s underlying cardiovascular and hepatic dysregulation. Here, Dr Shalini discusses a case study where a fixed dose combination of a sodium/glucose cotransporter-2 inhibitor (SGLT-2i) and dipeptidyl peptidase-4 enzyme inhibitor (DPP-4i) provided benefits for both glucose control and cardiovascular risk reduction.
The WHO defines long COVID as a condition that occurs 3 months from COVID-19 onset, whose symptoms last ≥2 months and cannot be attributed to an alternative diagnosis. In an interview with MIMS Doctor, Professor Ghassan Dbaibo of the Center for Infectious Diseases, American University of Beirut, Beirut, Lebanon, describes the evolving attitudes towards long COVID among healthcare professionals (HCPs), some unexpected predisposing factors, potential biological mechanisms behind prolonged symptom duration and shares data on vaccination’s protective effects against long COVID.
part of the leading Italian Pharmaceutical Company in the world, the Menarini
Group, is set to bring a revolutionary approach to dermatology and aesthetic
medicine treatments with the new Definisse™ range of facial fillers. The
Definisse™ range of hyaluronic acid (HA) fillers boasts a novel, hi-tech
stable and elastic 3D matrix developed using innovative EXcellent
Three-dimensional Reticulation (XTR™) Technology, allowing good volumizing
capability and providing predictable, long-lasting, and safe results. The
filler range is now available in India, Singapore, Thailand, and the
Philippines, and is set to launch in Malaysia and Indonesia in 2024. The Definisse™
filler range will strengthen Menarini’s existing dermatology and aesthetic
portfolio in Asia.
At the Novugen Expert Forum held in Penang, Malaysia in 2022, orthopaedic surgeon Dato’ Dr Lee Keat Hwa discussed the challenges of gout diagnosis and introduced a hyperuricaemia treatment option with a lower incidence of hypersensitivity.